How to manage asthma in a food-allergic patient: A practical approach
- PMID: 40771710
- PMCID: PMC12322906
- DOI: 10.2500/jfa.2025.7.250008
How to manage asthma in a food-allergic patient: A practical approach
Abstract
This article examines the intricate interplay between food allergy and asthma by focusing on the challenges of managing food allergy in patients with asthma. Although asthma is a prevalent comorbidity in food allergy, often > 50% among older children, its impact on food allergy outcomes remains not fully understood. Studies indicate a higher prevalence of asthma among individuals experiencing fatal anaphylaxis, yet there is no consistent evidence that supports a direct causal link between food allergy and the development of asthma. Clinicians and patients often overestimate asthma control, which leads to underestimated risks associated with severe food allergy reactions. This article underscores the critical need for optimal asthma control before and during oral food challenges and dietary advancement therapies, highlighting the heightened risk of severe reactions in individuals with poorly controlled asthma. Whereas biologics such as omalizumab show promise in enhancing asthma control and increasing food allergy thresholds, a comprehensive, multifaceted approach that involves diligent asthma management, patient education, and appropriate treatment strategies is essential for ensuring safe and effective management of food allergy in individuals with asthma. Integrated management, which addresses both conditions concurrently, is vital for improving patient safety and quality of life.
Keywords: anaphylaxis; asthma; asthma control; dietary advancement therapies; food allergy; food ladders; oral food challenge; oral immunotherapy.
Copyright © 2025, The Author(s). Published by OceanSide Publications, Inc., U.S.A.
Conflict of interest statement
D.P. Mack has provided consultation and speaker services for DBV, Bausch Health, ALK-Abello, Medexus, Covis, Sanofi, and is an investigator for DBV, ALK-Abello, Sanofi, Astra-Zeneca
Similar articles
-
Probiotics in infants for prevention of allergic disease.Cochrane Database Syst Rev. 2025 Jun 13;6(6):CD006475. doi: 10.1002/14651858.CD006475.pub3. Cochrane Database Syst Rev. 2025. PMID: 40511642 Review.
-
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601. Zhonghua Jie He He Hu Xi Za Zhi. 2025. PMID: 40050074 Chinese.
-
Allergen-specific oral immunotherapy for peanut allergy.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009014. doi: 10.1002/14651858.CD009014.pub2. Cochrane Database Syst Rev. 2012. PMID: 22972130 Free PMC article.
-
The Role of Omalizumab as an Adjunct to Oral Immunotherapy in Pediatric Food Allergy: A Systematic Review.Cureus. 2025 Jun 8;17(6):e85550. doi: 10.7759/cureus.85550. eCollection 2025 Jun. Cureus. 2025. PMID: 40630369 Free PMC article. Review.
-
Skin care interventions in infants for preventing eczema and food allergy.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013534. doi: 10.1002/14651858.CD013534.pub3. Cochrane Database Syst Rev. 2022. PMID: 36373988 Free PMC article.
References
LinkOut - more resources
Full Text Sources